Pfizer Inc. (NYSE:PFE) traded 12.94 Million shares on last trading day with closing price of $34.26. Company gross margin stands at 77.80% whereas its return on investment (ROI) is 7.30%. Stock value has moved between $27.85 – 37.24 in last one year. Analyst’s mean target price for Pfizer Inc. (NYSE:PFE) is $39.47 while analysts mean recommendation is 2.20. PFE EPS growth this year and EPS growth next year is -21.50%, 7.56% respectively.
Pfizer Inc. (NYSE:PFE) said Monday that it has decided not to split into two separate publicly-traded companies, something the drug giant had been mulling over for years, but reignited after its proposed merger with Allergan PLC fell through. The company said it determined that the best course to maximize shareholder value was to manage its two distinct businesses–Pfizer Innovative Health and Pfizer Essential Health– as units within Pfizer.
HollySys Automation Technologies, Ltd.
... read more at: http://www.benchmarkmonitor.com/pfizer-inc-nysepfe-decides-not-to-split-into-2-publicly-traded-companies-hollysys-automation-technologies-nasdaqholi-gw-pharmaceuticals-nasdaqgwph-deutsche-bank-ag-nysedb/1895372/